Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection Video Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating…Certara2025 年 10 月 16 日
Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton Video Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton Hear from Certara experts on how Certara IQ modernizes QSP modeling with AI, collaboration tools,…Certara2025 年 10 月 16 日
PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software Live Events PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software – Scarman, Coventry, UKCertara2025 年 10 月 14 日
C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions White Paper C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions Replace or waive TQT studies with validated C-QT analysis strategies accepted by FDA, EMA, PMDA.…Certara2025 年 10 月 3 日
Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Case Study Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准 Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…Certara2025 年 10 月 2 日
Best Practices in Clinical Pharmacology Gap Analysis Blog 临床药理学差距分析最佳实践 2025 年 9 月 19 日 Submitting your New Drug Application (NDA) to the FDA is the ultimate…Certara2025 年 9 月 19 日
Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool Announcement Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool RADNOR, Pa. – 2025 年 9 月 17 日 – Certara, Inc. (纳斯达克股票代码:CERT), a global leader in…Certara2025 年 9 月 17 日
Redefining Every Stage of Investment (RESI) Seed to Exit Conference Redefining Every Stage of Investment (RESI) Seed to Exit –Certara2025 年 9 月 5 日